The economic burden of mental disorders in China, 2005-2013: Implications for health policy

BMC Psychiatry

Volumn 16, Issue 1, 2016, Pages

  Xu, Junfang ^a,b   Wang, Jian ^a   Wimo, Anders ^b   Qiu, Chengxuan ^b  

^a SHANDONG UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

China; Costs; Economic burden; Health policy; Mental disorders; Mental health

Indexed keywords

ADULT; ARTICLE; CHINA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMIC EVALUATION; ELECTRONIC HEALTH RECORD; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; PREVALENCE; PSYCHOLOGICAL WELL BEING; ADOLESCENT; COST OF ILLNESS; ECONOMICS; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; CHINA; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH POLICY; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; YOUNG ADULT;

EID: 84968764962     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-016-0839-0     Document Type: Article

References (34)

1. World Health Organization. The World Health Report 2007 - A safer future global public health security in the 21st century. http://www.who.int/whr/2007/whr07_en.pdf?ua=1. Accessed 02 Oct 2015.
2. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari HE, Charlson FJ, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575-86.
3. World Health Organization (WHO). The global burden of disease: 2010 update. Geneva: WHO; 2011.
4. World Health Organization (WHO). Mental health action plan 2013-2020. http://apps.who.int/iris/bitstream/10665/89966/1/9789241506021_eng.pdf. Accessed 26 Sept 2015.
5. Phillips MR, Zhang J, Shi Q, Song ZQ, Ding ZJ, Pang ST, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet. 2009;373:2041-53.
6. Chinese National Health and Family Planning Commission and Chinese Government. China National Mental Health Working plan (2015-2020) (in Chinese). http://www.gov.cn/zhengce/content/2015-06/18/content_9860.htm. Accessed 18 Oct 2015.
7. Chen H, Phillips M, Cheng H, Chen Q, Chen X, Fralick D, et al. Mental Health Law of the People's Republic of China (English translation with annotations): Translated and annotated version of China's new Mental Health Law. Shanghai Arch Psychiatry. 2012;24:305-21.
8. Yang LH, Lo G, WonPat-Borja AJ, Singla DR, Link BG, Phillips MR. Effects of labeling and interpersonal contact upon attitudes towards schizophrenia: implications for reducing mental illness stigma in urban China. Soc Psychiatry Psychiatr Epidemiol. 2012;47:1459-73.
9. Shiffman J, Smith S. Generation of political priority for global health initiatives: a framework and case study of maternal mortality. Lancet. 2007;370:1370-9.
10. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, et al. Grand challenges in global mental health. Nature. 2011;475:27-30.
11. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197-223.
12. Eaton WW, Martins SS, Nestadt G, Bienvenu OJ, Clarke D, Alesandre P. The burden of mental disorders. Epidemiol Rev. 2008;30:1-14.
13. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:718-79.
14. Chevreul K, Prigent A, Bourmaud A, Leboyer M, Durand-Zaleski I. The cost of mental disorders in France. Eur Neuropsychopharmacol. 2013;23:879-86.
15. Fineberg NA, Haddad PM, Carpenter L, Gannon B, Sharpe R, Young AH, et al. The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol. 2013;27:761-70.
16. DiLuca M, Olesen J. The cost of brain diseases: a burden or a challenge? Neuron. 2014;82:1205-8.
17. Hu SL. The study methods of economic burden of disease. Chin Health Econ. 1991;11:45-7.
18. Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76:155-62.
19. Bloom DE, Cafiero ET, Jane-Llopis E. The global economic burden of non-communicable diseases: a report by the World Economic Forum and the Harvard School of Public Health. Geneva: World Economic Forum; 2011.
20. OECD. Fit Mind, Fit Job: From Evidence to Practice in Mental Health and Work, OECD Publishing, 2015, Paris. http://dx.doi.org/10.1787/9789264228283-en.
21. Alcorn T, Bao B. China progresses with health reform but challenges remain. Lancet. 2011;377:1557-8.
22. Field MJ, Lo B. Conflict of interest in medical research, education, and practice. Washington D.C.: National Academies Press; 2009.
23. Wang JY, Probst JC, Stoskopf CH, Sanders JM, McTigue JF. Information asymmetry and performance tilting in hospitals: a national empirical study. Health Econ. 2011;20:1487-506.
24. World Health Organization (WHO). Atlas: Mental Health Resources in the World. WHO: Geneva; 2005.
25. Patel V, Chisholm D, Kirkwood BR, Mabey D. Prioritizing health problems in women in developing countries: comparing the financial burden of reproductive tract infections, anaemia and depressive disorders in a community survey in India. Trop Med Int Health. 2007;12:130-9.
26. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851-8.
27. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72:334-41.
28. Haro JM, Tyrovolas S, Garin N, Diaz-Torne C, Carmona L, Sanchez-Riera L, et al. The burden of disease in Spain: results from the global burden of disease study 2010. BMC Med. 2014;12:1-25.
29. Fazel S, Wolf A, Palm C, Lichtenstein P. Depression and violence: a Swedish population study. Lancet Psychiatry. 2015;2:224-32.
30. Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA. 2007;298:1794-6.
31. Study on the economic burden of Shigellosis patients and their willingness to pay of Shigella vaccine in Zhengding county, Hebei province. Shanghai: Fudan University; 2004.
32. Beddington J, Cooper CL, Field J. The mental wealth of nations. Nature. 2008;455:1057-60.
33. Cyranoski D. China tackles surge in mental disorders. Nature. 2010;468:145.
34. Zhang Z, Zhai J, Wei Q, Qi J, Guo X, Zhao J. Cost-effectiveness analysis of psychosocial intervention for early stage schizophrenia in China: a randomized, one-year study. BMC Psychiatry. 2014;14:212.